Clinical Trial: A prospective study evaluating the safety and efficacy of yttrium [90Y] carbon microspheres radioembolization in patients with previously treated hepatocellular carcinoma (China)

Posted On: 2026-09-07

China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A prospective study evaluating the safety and efficacy of yttrium [90Y] carbon microspheres radioembolization in patients with previously treated hepatocellular carcinoma'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131754

Registration Time: 2026/09/06

Type: Interventional study

Primary Sponsor: The First Affiliated Hospital of Zhengzhou University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=319823

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: A prospective study evaluating the safety and efficacy of yttrium [90Y] carbon microspheres radioembolization in patients with previously treated hepatocellular carcinoma (China)